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Autoimmune processes can be found physiologically, as a
natural phenomenon in humans. Awide array of surveillance
mechanisms, cells with regulatory properties, and tolerance
mechanisms exists to control and decelerate autoimmunity
and to avoid the development of autoimmune diseases. How-
ever, when not properly controlled, the intricate interplay of
genetic, environmental, and immunological factors leads to
the development of these debilitating diseases. The immune
system has multiple levels of negative feedback mechanisms
that dampen immune responses and counteract the estab-
lishment of chronic and destructive immunity. Exponentially
growing knowledge on inflammatorymediators not only aids
us in the follow-up of ongoing autoimmune processes, even-
tually full-blown autoimmune diseases, but also provides a
tool to target and control these entities. Following inflamma-
tory mediators reflecting autoimmunity helps us to intervene
rapidly, before the eventual development of the disease and
by doing so organ damage can be prevented. Knowledge and
understanding of the pathogenicmechanisms that contribute
to these conditions can lead to the development of novel
diagnostic strategies and future effective therapies, providing
better life expectancies to patients with autoimmune diseases.
In this special issue we present original research articles
as well as review papers on the role of various inflammatory
mediators in autoimmunity and autoimmune diseases.
The first review article from the editors gives an overview
of the most important aspects in the pathogenesis of autoim-
mune diseases, with a special emphasis on the derailed
balance between regulatory and Th17 cells. Additionally, we
depict a cytokine imbalance, which gives rise to a biased T
cell homeostasis in these patients. The review also portrays
the multifaceted role of dendritic cells in the pathogenesis of
autoimmunity; finally we describe the function and role of
extracellular vesicles in particular autoimmune diseases.
Thepaper byN.Marton et al. describes the diverse roles of
Src-like adaptor proteins (SLAP-1 and SLAP-2), their role in
immunoregulation, and their effects on intracellular signal-
ing pathways. The paper by C. Burbano et al. depicts the role
of microparticles as modulatory structures in autoimmune
processes and also introduces recent findings on micropar-
ticles in the pathogenesis in RA and SLE. The paper by S. G.
Bourgoin et al. describes the effect of lysophosphatidic acid
(LPA) on T cell recruitment via CXCL13 synthesis and its
participation in inflammatory response regulation.
Thedevelopment of lung fibrosis is a pathological process,
characterized by abnormal accumulation of fibroblasts in the
alveolar interstitium. The research article by P. Y. Cohen et
al. depicts interesting aspects in the disease development
in a mouse model by using gene chip analysis. The analy-
sis concluded that lung myofibroblasts downregulated Thy1
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expression and diminished the in vivo inflammatory milieu,
indicating that inflammation is not essential for evolution
of fibrosis. The paper by C. B. Holt el al. describes the
role of Ficolin B in diabetic kidney diseases in a mouse
model of type I diabetes and concludes that the molecule
has no effect on diabetes-induced changes on the kidneys,
opposed to the negative role of mannan-binding lectin in the
pathogenesis. The next chapter of the special issue including
5 papers introduces various pathogenic aspects in systemic
autoimmune and rheumatic diseases. In this unit, the articles
introduce the clinical and immunoserological characteristics
of rheumatic diseases with coinciding psoriasis, the role
of progranulin in association with disease activity in RA
patients, and a review article summarizes the role of poly
(ADP-ribose) polymerase 1 in RA. A. A. S. S. K. Dharmapatni
et al. in their paper describe the beneficial effects of Embelin,
a XIAP inhibitor in a mouse model of collagen-induced
arthritis, indicated by suppressed inflammation and reduced
levels of the systemic bone resorptionmarker, CTX-1. Finally,
in this section patients with ankylosing spondylitis were
assessed and found that serum IL-6 correlated with ESR and
CRP levels, making IL-6 a potentially important biomarker
in the disease.
In this special issue we also depict various aspects in
the pathogenesis of inflammatory bowel diseases (IBD). The
paper by B. R. R. de Mattos et al. summarizes the latest
findings in the immunological pathomechanism of IBDs and
depicts the role of biologicals in the treatment while the
paper by L. M. Medrano et al. describes that the analysis of
a particular set of genes is a useful tool in the assessment of
response to infliximab in Crohn’s disease.
Follicular helper T cells (TFH) have been described to
play a pivotal role in the initiation and perturbation of
autoimmuneprocesses leading to the development of autoim-
mune diseases. The paper by K. Szabo et al. suggests that in
Sjo¨gren’s syndrome the presence of TFH cells in labial salivary
gland biopsies at the disease onset is a good biomarker and
may predict amore pronounced clinical course of the disease.
The paper by X. Fan et al. describes the pathogenic role of
TFH cells in human neuroautoimmune diseases and portrays
their animal models.
This issue also illustrates the usefulness of inflammatory
mediators in ocular manifestations of autoimmune diseases.
The paper by A. Rentka et al. describes decreased levels of
vascular endothelial growth factor (VEGF) in tear samples of
patients with systemic sclerosis, while the paper by S. Sharma
et al. reports from a study using a multiplex immunoassay
that elevated serum levels of soluble TNF receptors and
adhesion molecules are associated with diabetic retinopathy
in patients with type-1 diabetes.
This special issue encompasses basic, molecular mecha-
nisms of the pathogenesis in connection with autoimmune
processes and autoimmune diseases, illustrating useful cel-
lular and molecular mediators of inflammation. We believe
that these datamay contribute to improved tests for diagnosis
and improve our knowledge of the underlying disturbances in
the immune system in these hitherto unexplained disorders
and hopefully these mediators of inflammation will be useful
therapeutic targets in the futuremanagement of autoimmune
diseases.
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